Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer: Repopulation as a cause of treatment failure?

被引：38

作者：

Brade, AM ^{[1
]}

Tannock, IF

机构：

[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[2] Univ Toronto, Toronto, ON M4X 1K9, Canada

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 07期

关键词：

D O I：

10.1200/JCO.2005.04.9676

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1020 / 1022

页数：3

共 16 条

[1] Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial [J].

Bentzen, SM ;

Atasoy, BM ;

Daley, FM ;

Dische, S ;

Richman, PI ;

Saunders, MI ;

Trott, KR ;

Wilson, GD .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5560-5567

[2]

BONNER JA, IN PRESS N ENGL J ME

[3] Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741 [J].

Citron, ML ;

Berry, DA ;

Cirrincione, C ;

Hudis, C ;

Winer, EP ;

Gradishar, WJ ;

Davidson, NE ;

Martino, S ;

Livingston, R ;

Ingle, JN ;

Perez, EA ;

Carpenter, J ;

Hurd, D ;

Holland, JF ;

Smith, BL ;

Sartor, CI ;

Leung, EH ;

Abrams, J ;

Schilsky, RL ;

Muss, HB ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1431-1439

[4] Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer [J].

De Ruysscher, D ;

Pijls-Johannesma, M ;

Bentzen, SM ;

Minken, A ;

Wanders, R ;

Lutgens, L ;

Hochstenbag, M ;

Boersma, L ;

Wouters, B ;

Lammering, G ;

Vansteenkiste, J ;

Lambin, P .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1057-1063

[5] A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study [J].

Dy, GK ;

Miller, AA ;

Mandrekar, SJ ;

Aubry, MC ;

Langdon, RM ;

Morton, RF ;

Schild, SE ;

Jett, JR ;

Adjei, AA .

ANNALS OF ONCOLOGY, 2005, 16 (11) :1811-1816

[6] Emergent technologies for 3-dimensional image-guided radiation delivery [J].

Jaffray, DA .

SEMINARS IN RADIATION ONCOLOGY, 2005, 15 (03) :208-216

[7]

JAMES LE, 2003, LUNG CANCER S4, V41, pS23

[8] Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: A randomized study [J].

Jeremic, B ;

Shibamoto, Y ;

Acimovic, L ;

Milisavljevic, S .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :893-900

[9] Repopulation of cancer cells during therapy: An important cause of treatment failure [J].

Kim, JJ ;

Tannock, IF .

NATURE REVIEWS CANCER, 2005, 5 (07) :516-525

[10] Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein - A phase II clinical trial [J].

Krug, LM ;

Crapanzano, JP ;

Azzoli, CG ;

Miller, VA ;

Rizvi, N ;

Gomez, J ;

Kris, MG ;

Pizzo, B ;

Tyson, L ;

Dunne, M ;

Heelan, RT .

CANCER, 2005, 103 (10) :2128-2131

← 1 2 →